SCHEMBL9559331

SCHEMBL9559331

CC(C)CC1C(=O)Nc2cc3oc(-c4ccncc4)nc3cc21

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.44
KDM4E B2RXH2 4/20 0.44
ALDH1A1 P00352 4/20 0.44
HPGD P15428 4/20 0.44
TP53 P04637 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
PIK3CB P42338 2/20 0.40
PIK3CA P42336 1/20 0.40
TSHR P16473 1/20 0.39
THRB P10828 1/20 0.37
HDAC6 Q9UBN7 1/20 0.36
MAPT P10636 1/20 0.36
AAK1 Q2M2I8 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9559413 0.88 HSD17B10 (0.43) HSD17B10KDM4EALDH1A1HPGDTP53
SCHEMBL9559370 0.84 PIK3CB (0.42) HSD17B10KDM4EALDH1A1HPGDTP53
SCHEMBL9559357 0.82 PDE3B (0.45) HSD17B10KDM4EALDH1A1HPGDTP53
SCHEMBL9833576 0.77 PDE4A (0.49) HSD17B10KDM4EALDH1A1HPGDNPC1
SCHEMBL9559252 0.75 PIK3CB (0.41) HSD17B10KDM4EALDH1A1HPGDTP53
SCHEMBL9833587 0.71 KDM4E (0.41) HSD17B10KDM4EALDH1A1TP53TSHR
SCHEMBL11020209 0.71 HPGD (0.47) HSD17B10KDM4EALDH1A1HPGDTP53
SCHEMBL9559267 0.69 PDE3B (0.55) HSD17B10KDM4EALDH1A1HPGDTP53
SCHEMBL9559277 0.69 ALDH1A1 (0.43) HSD17B10KDM4EALDH1A1HPGDTP53
SCHEMBL9831445 0.68 MAPT (0.50) HSD17B10KDM4EALDH1A1HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0334289-B1 HETEROCYCLIC SUBSTITUTED 5,7-DIHYDROPYRROLO (3,2-F) BENZOXAZOL-6-ONES, PROCESS FOR THEIR PREPARATION AND DRUGS CONTAINING SAME Roche Diagnostics GmbH (DE) 1993-06-16 EP disclosed
US-5057526-A Immunological disorders, suppress organ rejection BOEHRINGER MANNHEIM GMBH (DE) 1991-10-15 US disclosed